Sleep movement disorder is a condition in which the person has difficulty in maintaining sleep. It is characterized by involuntary movements of the limbs, head, and trunk during sleep. The disorder can be caused due to various reasons such as stress, anxiety, depression or other medical conditions. Sleep movement disorder can also be caused due to certain medications that are used for treating other conditions such as Parkinson's disease or epilepsy. Benzodiazepines are drugs that are used for treating insomnia and anxiety disorders. Opioids are drugs that act on opioid receptors in the brain and reduce pain perception by binding to them. Anticonvulsants are drugs that inhibit neuronal activity and prevent seizures from occurring while sleeping. Sleep movement disorder drug market is expected to grow at a CAGR of 7% during the forecast period from 2021-2030.
Some Of The Growth Factors Of This Market:
- Increasing prevalence rates for sleep disorders such as obstructive sleep apnea and restless leg syndrome are the major factors driving the growth of the global sleep movement disorder drug market.
- Increasing awareness about the benefits associated with treatment for these disorders will also drive the growth of this market.
- Lack of awareness about these disorders and lack of access to treatment facilities are some factors that may hamper this market's growth.
Industry Growth Insights published a new data on “Sleep Movement Disorder Drug Market”. The research report is titled “Sleep Movement Disorder Drug Market research by Types (Benzodiazepines, Opioids, Anticonvulsants, Others, Sleep Movement Disorder Dru), By Applications (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Players/Companies Cardinal Health, Mylan, Teva, Shermco, Vollin Holdings, Allergan, Pfizer, GlaxoSmithKline, BD, Sleep Movement Disorder Dru”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sleep Movement Disorder Drug Market Research Report
By Type
Benzodiazepines, Opioids, Anticonvulsants, Others, Sleep Movement Disorder Dru
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Cardinal Health, Mylan, Teva, Shermco, Vollin Holdings, Allergan, Pfizer, GlaxoSmithKline, BD, Sleep Movement Disorder Dru
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Sleep Movement Disorder Drug Market Report Segments:
The global Sleep Movement Disorder Drug market is segmented on the basis of:
Types
Benzodiazepines, Opioids, Anticonvulsants, Others, Sleep Movement Disorder Dru
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cardinal Health
- Mylan
- Teva
- Shermco
- Vollin Holdings
- Allergan
- Pfizer
- GlaxoSmithKline
- BD
- Sleep Movement Disorder Dru
Highlights of The Sleep Movement Disorder Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Benzodiazepines
- Opioids
- Anticonvulsants
- Others
- Sleep Movement Disorder Dru
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sleep Movement Disorder Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sleep movement disorder drug is a medication used to treat sleep apnea and other sleep disorders.
Some of the key players operating in the sleep movement disorder drug market are Cardinal Health, Mylan, Teva, Shermco, Vollin Holdings, Allergan, Pfizer, GlaxoSmithKline, BD, Sleep Movement Disorder Dru.
The sleep movement disorder drug market is expected to grow at a compound annual growth rate of 7%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Sleep Movement Disorder Drug Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Sleep Movement Disorder Drug Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Sleep Movement Disorder Drug Market - Supply Chain
4.5. Global Sleep Movement Disorder Drug Market Forecast
4.5.1. Sleep Movement Disorder Drug Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Sleep Movement Disorder Drug Market Size (000 Units) and Y-o-Y Growth
4.5.3. Sleep Movement Disorder Drug Market Absolute $ Opportunity
5. Global Sleep Movement Disorder Drug Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Sleep Movement Disorder Drug Market Size and Volume Forecast by Type
5.3.1. Benzodiazepines
5.3.2. Opioids
5.3.3. Anticonvulsants
5.3.4. Others
5.3.5. Sleep Movement Disorder Dru
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Sleep Movement Disorder Drug Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Sleep Movement Disorder Drug Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Sleep Movement Disorder Drug Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Sleep Movement Disorder Drug Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Sleep Movement Disorder Drug Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Sleep Movement Disorder Drug Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Sleep Movement Disorder Drug Demand Share Forecast, 2019-2026
9. North America Sleep Movement Disorder Drug Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Sleep Movement Disorder Drug Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Sleep Movement Disorder Drug Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Sleep Movement Disorder Drug Market Size and Volume Forecast by Type
9.7.1. Benzodiazepines
9.7.2. Opioids
9.7.3. Anticonvulsants
9.7.4. Others
9.7.5. Sleep Movement Disorder Dru
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Sleep Movement Disorder Drug Demand Share Forecast, 2019-2026
10. Latin America Sleep Movement Disorder Drug Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Sleep Movement Disorder Drug Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Sleep Movement Disorder Drug Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Sleep Movement Disorder Drug Market Size and Volume Forecast by Type
10.7.1. Benzodiazepines
10.7.2. Opioids
10.7.3. Anticonvulsants
10.7.4. Others
10.7.5. Sleep Movement Disorder Dru
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Sleep Movement Disorder Drug Demand Share Forecast, 2019-2026
11. Europe Sleep Movement Disorder Drug Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Sleep Movement Disorder Drug Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Sleep Movement Disorder Drug Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Sleep Movement Disorder Drug Market Size and Volume Forecast by Type
11.7.1. Benzodiazepines
11.7.2. Opioids
11.7.3. Anticonvulsants
11.7.4. Others
11.7.5. Sleep Movement Disorder Dru
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Sleep Movement Disorder Drug Demand Share, 2019-2026
12. Asia Pacific Sleep Movement Disorder Drug Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Sleep Movement Disorder Drug Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Sleep Movement Disorder Drug Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Sleep Movement Disorder Drug Market Size and Volume Forecast by Type
12.7.1. Benzodiazepines
12.7.2. Opioids
12.7.3. Anticonvulsants
12.7.4. Others
12.7.5. Sleep Movement Disorder Dru
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Sleep Movement Disorder Drug Demand Share, 2019-2026
13. Middle East & Africa Sleep Movement Disorder Drug Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Sleep Movement Disorder Drug Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Sleep Movement Disorder Drug Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Sleep Movement Disorder Drug Market Size and Volume Forecast by Type
13.7.1. Benzodiazepines
13.7.2. Opioids
13.7.3. Anticonvulsants
13.7.4. Others
13.7.5. Sleep Movement Disorder Dru
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Sleep Movement Disorder Drug Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Sleep Movement Disorder Drug Market: Market Share Analysis
14.2. Sleep Movement Disorder Drug Distributors and Customers
14.3. Sleep Movement Disorder Drug Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Cardinal Health
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Mylan
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Teva
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Shermco
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Vollin Holdings
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Allergan
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Pfizer
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. GlaxoSmithKline
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. BD
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sleep Movement Disorder Dru
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
